共 50 条
Inhalation versus intravenous anaesthesia for adults undergoing on-pump or off-pump coronary artery bypass grafting: A systematic review and meta-analysis of randomized controlled trials
被引:22
|作者:
El Dib, Regina
[1
,2
,3
]
Guimaraes Pereira, Jose E.
[2
]
Agarwal, Arnav
[4
]
Gomaa, Huda
[5
]
Ayala, Ana Patricia
[6
]
Botan, Andresa Graciutti
[1
]
Braz, Leandro Gobbo
[2
]
de Oliveira, Luciane Dias
[1
]
Lopes, Luciane Cruz
[7
]
Mathew, Preethy J.
[8
]
机构:
[1] Univ Estadual Paulista, UNESP, Inst Sci & Technol, Sao Jose Dos Campos, SP, Brazil
[2] Univ Estadual Paulista, UNESP, Botucatu Med Sch, Dept Anaesthesiol, Botucatu, SP, Brazil
[3] McMaster Univ, McMaster Inst Urol, Hamilton, ON, Canada
[4] Univ Toronto, Fac Med, Toronto, ON, Canada
[5] Tanta Chest Hosp, Dept Pharm, Tanta, Egypt
[6] Univ Toronto, Gerstein Sci Informat Ctr, Toronto, ON, Canada
[7] Univ Sorocaba, Pharmaceut Sci Grad Course, Sao Paulo, Brazil
[8] Post Grad Inst Med Educ & Res, Dept Anaesthesia & Intens Care, Chandigarh, India
关键词:
Inhalation anaesthesia;
Intravenous anaesthesia;
On-pump;
Off-pump;
Coronary artery bypass grafting;
Grade;
Systematic review;
Randomized controlled trials;
PRESERVES MYOCARDIAL-FUNCTION;
PROPOFOL-BASED ANESTHESIA;
VOLATILE ANESTHETICS;
CARDIOPULMONARY BYPASS;
CARDIAC-SURGERY;
SUFENTANIL ANESTHESIA;
MIDAZOLAM-SUFENTANIL;
TRACHEAL EXTUBATION;
HEMODYNAMIC-CHANGES;
SEVOFLURANE;
D O I:
10.1016/j.jclinane.2017.05.010
中图分类号:
R614 [麻醉学];
学科分类号:
100217 ;
摘要:
Study objective: To compare the use of inhalation versus intravenous anaesthesia for adults undergoing on-pump or off-pump coronary artery bypass grafting. Design: A systematic review. Setting: A hospital-affiliated university. Measurements: The following databases were searched: the Cochrane Central Register of Controlled Trials (CENTRAL 2016, Issue 10), MEDLINE, EMBASE, and LILACS (from inception to October 2016). We used the GRADE approach to rate overall certainty of the evidence. Results: In total we included 58 studies with a total of 6105 participants. The methodological quality was difficult to assess as it was poorly reported in 35 included studies (three or more domains were rated as unclear risk of bias). Two trials of sevoflurane showed a statistically significant reduction in death within 180 to 365 days of surgery (on-pump) (RR 4.10, 95% CI 1.42 to 11.79; p = 0.009; I-2 = not applicable; high quality of evidence). There was also a statistically significant difference favouring sevoflurane compared to propofol on both inotropic (RR 2.11, 95% CI 1.53 to 2.90; p < 0.00001; I-2 = 0%) and vasoconstrictor support needed (RR 1.51, 95% CI 1.04 to 2.22; p = 0.03; I-2 = 0%) after coronary artery bypass grafting on-pump. Two trials of sevoflurane (MD - 0.22, 95% CI - 0.41 to -0.03; p = 0.02; I-2 = 0%) and two further trials of desflurane (MD - 033, 95% CI -0.45 to - 0.20; p < 0.00001; I-2 = 82%) showed a statistically significant difference on cardiac index during and after coronary artery bypass grafting on-pump, respectively. Conclusions: There is high quality evidence that sevoflurane reduces death within 180 to 365 days of surgery and, inotropic and vasoconstrictor support compared to propofol for patients undergoing coronary artery bypass grafting. There is also some evidence showing that the cardiac index is minimally influenced by administration of sevoflurane and desflurane compared to propofol. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:127 / 138
页数:12
相关论文